European Companies Search Engine
State Aid (€234,773): NL_BZK_CSDO KvW3-00356-Slimme Tumor-targeting met Receptor Immunotherapie via Peptide-antibody Engineering Sat12 Jun 2025 State Aid Transparency (Direct grant/ Interest rate subsidy)
Overview
Text
| Country | Netherlands |
| Language | Dutch |
| Aid Measure Title | NL_BZK_CSDO KvW3-00356-Slimme Tumor-targeting met Receptor Immunotherapie via Peptide-antibody Engineering (en: NL_BZK_CSDO KvW3-00356-Smart Tumor-targeting with Receptor immunotherapy via Peptide antibody Engineering) |
| SA.Number | SA.119415 |
| Ref-no. | TM-12607363 |
| National ID | 24485070 |
| Beneficiary National ID Type | KvK nummer |
| Name of the beneficiary | Erasmus MC |
| Beneficiary Type | Only large enterprises |
| Region | West-Nederland |
| Sector (NACE) | Research and experimental development on natural sciences and engineering |
| Aid Instrument | Direct grant/ Interest rate subsidy |
| Objectives of the Aid | Industrial research (Art. 25(2)(b)) |
| Date of Granting | 12/06/2025 |
| Aid element, expressed as full amount | 234,773.00 EUR |
| Granting Authority Name | Kansen voor West (en: Opportunities for West) |
| Co-finance | ✓ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam, Netherlands.
The visualizations for "Erasmus MC - State Aid (€234,773): NL_BZK_CSDO KvW3-00356-Slimme Tumor-targeting met Receptor Immunotherapie via Peptide-antibody Engineering"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
